<img height="1" width="1" style="display:none" src="https://www.facebook.com/tr?id=780280282443813&amp;ev=PageView&amp;noscript=1">
search

    Evoke Pharma, Inc.

    verified_userVerify Profile
    Companies » Health Care » Pharmaceuticals & Biotechnology » Pharmaceuticals

    About Evoke Pharma, Inc.

    Evoke Pharma, Inc. (NASDAQ: EVOK) is a specialty pharmaceutical company focused primarily on the development of drugs to treat gastrointestinal (GI) diseases. The Company was established by experienced specialty pharmaceutical executives with a successful track record of acquiring, developing, registering, and marketing pharmaceutical products in the US. Source

    At A Glance

    • CAPITAL RAISE STATUS
      Not Currently Raising
    • FILING TYPE
      Public
    • PLATFORM TYPE
      NASDAQ
    • RAISED AMOUNT
      $X,XXX,XXX
    • PRE-MONEY EVAULATION
      $69,400,000
    • SIC CODE
      2834
    • NIN CODE
      ####
    • LEADERSHIP
      David A. Gonyer, R.Ph.
    • FOUNDED
      2007
    • EMPLOYEES
      0-10
    • SECTOR
      Pharmaceuticals & Biotechnology
    • SUBSECTOR
      Pharmaceuticals

    Company Tags

    No articles found.

    Systec & Solutions GmbH

    Systec & Solutions GmbH

    Systec & Solutions GmbH, with headquarters in Karlsruhe (Germany), is a specialize...

    Systec & Solutions GmbH, with headquarters in K...

    Filing Type:    PR
    Applied Science Products, Inc.

    Applied Science Products, Inc.

    Applied Science Products operates Advanced Plasma Products, Inc., a science and en...

    Applied Science Products operates Advanced Plas...

    Kerluxe, Inc.

    Kerluxe, Inc.

    The Kerluxe brand philosophy is to employ innovation synonymous with Swiss skincar...

    The Kerluxe brand philosophy is to employ innov...

    Fundraising Status:    EC
    Filing Type:    RA
    NeurMedix Inc.

    NeurMedix Inc.

    NeurMedix, Inc., is a clinical-stage biotechnology company that engages in develop...

    NeurMedix, Inc., is a clinical-stage biotechnol...

    Fundraising Status:    EC
    Filing Type:    RA
    Altimmune, Inc.

    Altimmune, Inc.

    Altimmune is a clinical-stage immunotherapeutics company focused on the developmen...

    Altimmune is a clinical-stage immunotherapeutic...

    Filing Type:    PU
    ESSA Pharma Inc.

    ESSA Pharma Inc.

    With a focus on the development of small molecule drugs for the treatment of cance...

    With a focus on the development of small molecu...

    Filing Type:    PU
    Ironwood Pharmaceuticals, Inc.

    Ironwood Pharmaceuticals, Inc.

    Ironwood Pharmaceuticals (Nasdaq: IRWD) is a GI-focused healthcare company dedicat...

    Ironwood Pharmaceuticals (Nasdaq: IRWD) is a GI...

    Filing Type:    PU
    Protagonist Therapeutics, Inc.

    Protagonist Therapeutics, Inc.

    Protagonist Therapeutics is a clinical stage biopharmaceutical company that utiliz...

    Protagonist Therapeutics is a clinical stage bi...

    Filing Type:    PU
    Albireo Pharma, Inc.

    Albireo Pharma, Inc.

    Albireo is a clinical-stage biopharmaceutical company focused on the development a...

    Albireo is a clinical-stage biopharmaceutical c...

    Filing Type:    PU
    ©2026 National Investor Network. All Rights Reserved.